Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Swanson

Showing results (31-40 of 61) with videos related to

Pageof 7
Sort By:
Cancer|October 8, 2004
A renal mass in the setting of a nonrenal malignancy: When is a renal tumor biopsy appropriate?Ricardo F Sánchez-Ortiz, Lydia T Madsen, Carlos E Bermejo, et al.
Cancer|July 14, 2011
Outcomes after prostate brachytherapy are even better than predictedSteven J Frank, Lawrence B Levy, Marco van Vulpen, et al.
International Journal of Radiation Oncology, Biology, Physics|February 4, 2012
Sexual function and the use of medical devices or drugs to optimize potency after prostate brachytherapyJ Taylor Whaley, Lawrence B Levy, David A Swanson, et al.
Urology|October 28, 2008
Randomized trial of adjuvant thalidomide versus observation in patients with completely resected high-risk renal cell carcinomaVitaly Margulis, Surena F Matin, Nizar Tannir, et al.
The Journal of Urology|December 11, 2003
Is there a role for surgery in the management of metastatic urothelial cancer? The M. D. Anderson experienceArlene O Siefker-Radtke, Garrett L Walsh, Louis L Pisters, et al.
Brachytherapy|March 8, 2013
An MRI-based dose--reponse analysis of urinary sphincter dose and urinary morbidity after brachytherapy for prostate cancer in a phase II prospective trialSteven P Register, Rajat J Kudchadker, Lawrence B Levy, et al.
The Journal of Urology|September 18, 2007
Cytoreductive nephrectomy for metastatic renal cell carcinoma with nonclear cell histologyWassim Kassouf, Ricardo Sanchez-Ortiz, Pheroze Tamboli, et al.
Brachytherapy|September 27, 2014
Sexual potency preservation and quality of life after prostate brachytherapy and low-dose tadalafilThomas J Pugh, Usama Mahmood, David A Swanson, et al.
Infection Control and Hospital Epidemiology|December 14, 2020
How relevant is the basic reproductive number computed during the coronavirus disease 2019 (COVID-19) pandemic, especially during lockdowns?Arni S R Srinivasa Rao, Steven G Krantz, Michael B Bonsall, et al.
Brachytherapy|June 26, 2012
Knife or needles? A cohort analysis of outcomes after radical prostatectomy or brachytherapy for men with low- or intermediate-risk adenocarcinoma of the prostateChristine M Fisher, Patricia Troncoso, David A Swanson, et al.
Pageof 7

Showing results (31-40 of 61) with videos related to

Sort By:
Pageof 7
Cancer|October 8, 2004
A renal mass in the setting of a nonrenal malignancy: When is a renal tumor biopsy appropriate?Ricardo F Sánchez-Ortiz, Lydia T Madsen, Carlos E Bermejo, et al.
Cancer|July 14, 2011
Outcomes after prostate brachytherapy are even better than predictedSteven J Frank, Lawrence B Levy, Marco van Vulpen, et al.
International Journal of Radiation Oncology, Biology, Physics|February 4, 2012
Sexual function and the use of medical devices or drugs to optimize potency after prostate brachytherapyJ Taylor Whaley, Lawrence B Levy, David A Swanson, et al.
Urology|October 28, 2008
Randomized trial of adjuvant thalidomide versus observation in patients with completely resected high-risk renal cell carcinomaVitaly Margulis, Surena F Matin, Nizar Tannir, et al.
The Journal of Urology|December 11, 2003
Is there a role for surgery in the management of metastatic urothelial cancer? The M. D. Anderson experienceArlene O Siefker-Radtke, Garrett L Walsh, Louis L Pisters, et al.
Brachytherapy|March 8, 2013
An MRI-based dose--reponse analysis of urinary sphincter dose and urinary morbidity after brachytherapy for prostate cancer in a phase II prospective trialSteven P Register, Rajat J Kudchadker, Lawrence B Levy, et al.
The Journal of Urology|September 18, 2007
Cytoreductive nephrectomy for metastatic renal cell carcinoma with nonclear cell histologyWassim Kassouf, Ricardo Sanchez-Ortiz, Pheroze Tamboli, et al.
Brachytherapy|September 27, 2014
Sexual potency preservation and quality of life after prostate brachytherapy and low-dose tadalafilThomas J Pugh, Usama Mahmood, David A Swanson, et al.
Infection Control and Hospital Epidemiology|December 14, 2020
How relevant is the basic reproductive number computed during the coronavirus disease 2019 (COVID-19) pandemic, especially during lockdowns?Arni S R Srinivasa Rao, Steven G Krantz, Michael B Bonsall, et al.
Brachytherapy|June 26, 2012
Knife or needles? A cohort analysis of outcomes after radical prostatectomy or brachytherapy for men with low- or intermediate-risk adenocarcinoma of the prostateChristine M Fisher, Patricia Troncoso, David A Swanson, et al.
Pageof 7